NasdaqGM - Nasdaq Real Time Price USD
Connect Biopharma Holdings Limited (CNTB)
0.7510
+0.0240
+(3.30%)
At close: May 16 at 4:00:00 PM EDT
0.7300
-0.03
(-4.20%)
Pre-Market: 4:46:58 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.27 | -0.29 | -0.98 | -0.88 |
| Low Estimate | -0.27 | -0.29 | -1.12 | -1.32 |
| High Estimate | -0.27 | -0.29 | -0.83 | -0.43 |
| Year Ago EPS | -- | -- | -0.28 | -0.98 |
Revenue Estimate
| Currency in CNY | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | 72.81M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 145.63M |
| Year Ago Sales | -- | -- | 188.91M | -- |
| Sales Growth (year/est) | -- | -- | -100.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2025 |
|---|---|
| EPS Est. | -0.26 |
| EPS Actual | -0.19 |
| Difference | 0.07 |
| Surprise % | 26.92% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.27 | -0.29 | -0.98 | -0.88 |
| 7 Days Ago | 0 | 0 | -0.65 | -0.34 |
| 30 Days Ago | 0 | 0 | -0.32 | -0.36 |
| 60 Days Ago | 0 | 0 | -0.32 | -0.36 |
| 90 Days Ago | 0 | 0 | 0 | -0.38 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CNTB | -- | -- | -248.21% | 10.26% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/17/2024 |
| Initiated | HC Wainwright & Co.: Buy | 3/4/2024 |
Related Tickers
PYPD PolyPid Ltd.
2.7450
-3.68%
MIST Milestone Pharmaceuticals Inc.
1.2200
+6.09%
APLT Applied Therapeutics, Inc.
0.6029
+22.82%
VTGN Vistagen Therapeutics, Inc.
2.4600
+6.96%
GRCE Grace Therapeutics, Inc.
2.8000
+1.82%
LPCN Lipocine Inc.
3.9900
+6.97%
XFOR X4 Pharmaceuticals, Inc.
2.9200
-3.31%
ENSC Ensysce Biosciences, Inc.
2.3400
+9.35%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
RLMD Relmada Therapeutics, Inc.
0.4610
+11.51%